Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders

Clinical trial NCT06118398 · UNKNOWN

Trial details

NCT number: NCT06118398
Sponsor: Feng Jinzhou
Status: UNKNOWN
Study type: OBSERVATIONAL

Neuromyelitis Optica Efgartigimod

Start date: 2023-11-05
Primary completion: 2024-11-05
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.